Home » Topics » BioWorld Science

BioWorld Science
RSS

Life Science Institute initiates exploratory clinical trial of CL-2020 in epidermolysis bullosa

Dec. 24, 2018

Phase II TRAXAR study does not meet primary endpoint

Dec. 24, 2018

Merck KGaA and Pfizer terminate JAVELIN Ovarian 100 study of avelumab

Dec. 24, 2018

FDA grants early approval for Ultomiris for the treatment of adults with PNH

Dec. 24, 2018

FDA approves Inbrija

Dec. 24, 2018

Suglat Tablets approved for additional indication of type 1 diabetes mellitus in Japan

Dec. 24, 2018

Novartis receives approval in the E.U. for expanded indication for Kisqali

Dec. 24, 2018

Elzonris receives FDA approval for the treatment of blastic plasmacytoid dendritic cell neoplasm

Dec. 24, 2018

MUC17 and PCNX1 as novel biomarkers of chemotherapy response in breast cancer

Dec. 24, 2018

Platform could prove broad strategy against emerging viruses

Dec. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...